Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 71 Records) |
Query Trace: Neoplasms and NFE2L2[original query] |
---|
Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients With Advanced NSCLC (NCI 10327): Rationale and Study Design. Clinical lung cancer 2020 Oct . Riess Jonathan W, Frankel Paul, Shackelford David, Dunphy Mark, Badawi Ramsey D, Nardo Lorenzo, Cherry Simon R, Lanza Ian, Reid Joel, Gonsalves Wilson I, Kunos Charles, Gandara David R, Lara Primo N, Newman Edward, Paik Paul |
Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. Scientific reports 2020 Nov 10 (1): 20243. Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L |
TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 11 34 (6): 1133-1142. Brown Noah A, Plouffe Komal R, Yilmaz Osman, Weindorf Steven C, Betz Bryan L, Carey Thomas E, Seethala Raja R, McHugh Jonathan B, Tomlins Scott A, Udager Aaron |
An Autophagy-Related Gene Signature Associated With Clinical Prognosis and Immune Microenvironment in Gliomas. Frontiers in oncology 2020 10 571189. Xu Yang, Li Renpeng, Li Xiaoxia, Dong Naijun, Wu Di, Hou Lin, Yin Kan, Zhao Chunh |
NFE2L2 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltration in Brain Lower Grade Glioma: A Pan-Cancer Analysis. Oxidative medicine and cellular longevity 2020 10 2020 3580719. Ju Qiang, Li Xinmei, Zhang Heng, Yan Songxia, Li Ying, Zhao Yanj |
KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials. Frontiers in oncology 2021 11 659200. Zhu Hongyuan, Xie Daipeng, Yu Yunfang, Yao Lintong, Xu Bin, Huang Luyu, Wu Shaowei, Li Fasheng, Zheng Yating, Liu Xinyi, Xie Wenzhuan, Huang Mengli, Li Hao, Zheng Shaopeng, Zhang Dongkun, Qiao Guibin, Chan Lawrence W C, Zhou Hai |
Somatic Mutations in Circulating Cell-Free DNA and Risk for Hepatocellular Carcinoma in Hispanics. International journal of molecular sciences 2021 Jul 22 (14): . Jiao Jingjing, Sanchez Jessica I, Thompson Erika J, Mao Xizeng, McCormick Joseph B, Fisher-Hoch Susan P, Futreal P Andrew, Zhang Jianhua, Beretta Lau |
The Impact of Durvalumab on Local-Regional Control in Stage III NSCLCs Treated With Chemoradiation and on KEAP1-NFE2L2-Mutant Tumors. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 5 16 (8): 1392-1402. Shaverdian Narek, Offin Michael, Shepherd Annemarie F, Simone Charles B, Gelblum Daphna Y, Wu Abraham J, Hellmann Matthew D, Rimner Andreas, Paik Paul K, Chaft Jamie E, Gomez Daniel |
Whole exome sequencing and deep sequencing of esophageal squamous cell carcinoma and adenocarcinoma in Japanese patients using the Japanese version of the Genome Atlas, JCGA. Esophagus : official journal of the Japan Esophageal Society 2021 Apr . Booka Eisuke, Tsubosa Yasuhiro, Yokota Tomoya, Mayanagi Shuhei, Ishii Kenjiro, Urakami Kenichi, Ohshima Keiichi, Ohnami Shumpei, Nagashima Takeshi, Yamaguchi K |
The role of functional polymorphisms in oxidative stress-related genes on early-stage breast cancer survival. The International journal of biological markers 2021 Apr 17246008211011177. Korobeinikova Erika, Ugenskiene Rasa, Insodaite Ruta, Rudzianskas Viktoras, Gudaitiene Jurgita, Juozaityte Elo |
Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations. Oncotarget 2021 4 12 (6): 578-588. Joshi Asim, Mishra Rohit, Desai Sanket, Chandrani Pratik, Kore Hitesh, Sunder Roma, Hait Supriya, Iyer Prajish, Trivedi Vaishakhi, Choughule Anuradha, Noronha Vanita, Joshi Amit, Patil Vijay, Menon Nandini, Kumar Rajiv, Prabhash Kumar, Dutt Am |
Genetic alterations in squamous cell lung cancer associated with idiopathic pulmonary fibrosis. International journal of cancer 2021 Feb . Hata Atsushi, Nakajima Takahiro, Matsusaka Keisuke, Fukuyo Masaki, Nakayama Manabu, Morimoto Junichi, Ito Yuki, Yamamoto Takayoshi, Sakairi Yuichi, Rahmutulla Bahityar, Ota Satoshi, Wada Hironobu, Suzuki Hidemi, Iwata Takekazu, Matsubara Hisahiro, Ohara Osamu, Yoshino Ichiro, Kaneda Atsus |
Multiomics analysis of tumor mutational burden across cancer types. Computational and structural biotechnology journal 2021 19 5637-5646. Li Lin, Bai Long, Lin Huan, Dong Lin, Zhang Rumeng, Cheng Xiao, Liu Zexian, Ouyang Yi, Ding Kesh |
Thioredoxin reductase-1 levels are associated with NRF2 pathway activation and tumor recurrence in non-small cell lung cancer. Free radical biology & medicine 2021 Oct 177 58-71. Delgobo Marina, Gonçalves Rosângela Mayer, Delazeri Marco Antônio, Falchetti Marcelo, Zandoná Alessandro, Nascimento das Neves Raquel, Almeida Karoline, Fagundes Adriane Cristina, Gelain Daniel Pens, Fracasso João Isidro, Macêdo Guilherme Baroni de, Priori Leonardo, Bassani Nicklas, Bishop Alexander James Roy, Forcelini Cassiano Mateus, Moreira José Cláudio Fonseca, Zanotto-Filho Alf |
Profile of esophageal squamous cell carcinoma mutations in Brazilian patients. Scientific reports 2021 10 11 (1): 20596. Munari Fernanda Franco, Dos Santos Wellington, Evangelista Adriane Feijó, Carvalho Ana Carolina, Pastrez Paula Aguiar, Bugatti Diego, Wohnrath Durval R, Scapulatempo-Neto Cristovam, Guimarães Denise Peixoto, Longatto-Filho Adhemar, Reis Rui Manu |
Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform. Clinical chemistry 2021 Jan . Giménez-Capitán Ana, Bracht Jillian, García Juan José, Jordana-Ariza Núria, García Beatriz, Garzón Mónica, Mayo-de-Las-Casas Clara, Viteri-Ramirez Santiago, Martinez-Bueno Alejandro, Aguilar Andrés, Sullivan Ivana-Gabriela, Johnson Eric, Huang Chung-Ying, Gerlach Jay L, Warren Sarah, Beechem Joseph M, Teixidó Cristina, Rosell Rafael, Reguart Noemí, Molina-Vila Miguel |
Genomic Profiling Identified Prognostic Biomarkers of Definitive Chemo-Radiotherapy Response in Esophageal Carcinoma. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): S13. Li L, Yuan S, Sun J, Yin Y, Cui J, Zhang J, Chen Y, Pang J, Yin J, Shao Y, Yu |
Survival Outcomes and Treatment Patterns in Patients With NFE2L2 and/or KEAP1 Mutation-Positive Advanced Squamous Cell NSCLC Using a Real-World Clinico-Genomic Database. Clinical lung cancer 2022 6 23 (6): 487-497. Wu Yanyu, Yin Yu, Crossland Victoria, Vincent Sylvie, Paik Paul K, Lineberry Neil, Faller Douglas |
Multi-omics analysis identifies distinct subtypes with clinical relevance in lung adenocarcinoma harboring KEAP1/NFE2L2. Journal of Cancer 2022 4 13 (5): 1512-1522. Yang Xiaodong, Li Ming, Chen Zhencong, Fan Xiaobin, Guo Liang, Jin Bo, Huang Yiwei, Wang Qun, Wu Liang, Zhan Che |
TIMP3 Gene Polymorphisms of -1296 T > C and -915 A > G Increase the Susceptibility to Arsenic-Induced Skin Cancer: A Cohort Study and In Silico Analysis of Mutation Impacts. International journal of molecular sciences 2022 12 23 (23): . Wu Meei-Maan, Chen Chi-Wei, Chen Chiu-Yi, Lee Chih-Hung, Chou Mark, Hsu Ling-I, Lee Te-Chang, Chen Chien-J |
Integrated analysis of racial disparities in genomic architecture identifies a trans-ancestry prognostic subtype in bladder cancer. Molecular oncology 2022 12 . Zhang Baifeng, Jia Peilin, Wang Jiayin, Pei Guangsheng, Wang Changxi, Pei Shimei, Li Xiangchun, Zhao Zhongming, Yi Xin, Guan Xin-Yuan, Huang |
A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer. Journal of cancer research and clinical oncology 2022 11 149 (1): 203-218. Jiang Xu, Ke Jing, Jia Lifeng, An Xiang, Ma Haiyu, Li Zhongwan, Yuan W |
Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2022 10 . Paik Paul K, Fan Pang-Dian, Qeriqi Besnik, Namakydoust Azadeh, Daly Bobby, Ahn Linda, Kim Rachel, Plodkowski Andrew, Ni Ai, Chang Jason, Fanaroff Rachel, Ladanyi Marc, de Stanchina Elisa, Rudin Charles |
Cuproptosis Combined with lncRNAs Predicts the Prognosis and Immune Microenvironment of Breast Cancer. Computational and mathematical methods in medicine 2022 10 2022 5422698. Zhang Liangping, Zhang Yujun, Bao Jianhang, Gao Wenshuo, Wang Dong, Pan H |
Prognostic Value and Immune Infiltration Analysis of Nuclear Factor Erythroid-2 Family Members in Ovarian Cancer. BioMed research international 2022 1 2022 8672258. Dou Rui, Wang Xiong, Zhang J |
Comprehensive analyses of the clinicopathological features and genomic mutations of combined hepatocellular-cholangiocarcinoma. Hepatology research : the official journal of the Japan Society of Hepatology 2023 9 . Takashi Ito, Takamichi Ishii, Haruhiko Takeda, Shinji Sumiyoshi, Katsuhiro Tomofuji, Satoshi Wakama, Kenta Makino, Hiroshi Horie, Ken Kumagai, Atsushi Takai, Elena Yukie Uebayashi, Satoshi Ogiso, Ken Fukumitsu, Hironori Haga, Hiroshi Seno, Etsuro Hata |
Towards Understanding the Key Signature Pathways Associated from Differentially Expressed Gene Analysis in an Indian Prostate Cancer Cohort. Diseases (Basel, Switzerland) 2023 5 11 (2): . Nidhi Shukla, Bhumandeep Kour, Devendra Sharma, Maneesh Vijayvargiya, T C Sadasukhi, Krishna Mohan Medicherla, Babita Malik, Bhawana Bissa, Sugunakar Vuree, Nirmal Kumar Lohiya, Prashanth Suravajha |
Noninvasive genomic profiling of somatic mutations in oral cavity cancers. Oral oncology 2023 4 140 106372. Xi Yuanxin, Negrao Marcelo V, Akagi Keiko, Xiao Weihong, Jiang Bo, Warner Sarah C, Dunn Joe Dan, Wang Jing, Symer David E, Gillison Maura |
Identification of molecular subtypes and a risk model based on inflammation-related genes in patients with low grade glioma. Heliyon 2023 12 9 (12): e22429. Cheng Long, Ya Song, Yimin Pan, Changwu |
Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab. JAMA network open 2023 1 6 (1): e2249591. Lebow Emily S, Shepherd Annemarie, Eichholz Jordan E, Offin Michael, Gelblum Daphna Y, Wu Abraham J, Simone Charles B, Schoenfeld Adam J, Jones David R, Rimner Andreas, Chaft Jamie E, Riaz Nadeem, Gomez Daniel R, Shaverdian Nar |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: